LANGUAGE AND DURATION

Language: English
Duration: 40 minutes, followed by questions from the audience

 

PRESENTER

  • Dr. Christina Lampe, Centre for Rare Diseases of the Department of Child Neurology, Epileptology and Social Medicine, Center for Paediatric and Adolescent Medicine, University Hospital of Gießen, Germany
  • Prof. Adriana Montano, Doisy Research Center, Department of Pediatrics and Department of Biochemistry and Molecular Biology School of Medicine, Saint Louis University, USA

 

LEARNING OBJECTIVES

  1. Using Case Studies to understand better how the multidisciplinary team approach to managing MPS patients is so vital
  2. Examining the role of the general paediatrician in coordinating local care and allied healthcare professionals through a typical case study
  3. Reviewing a case study demonstrating the importance of communication between centres, professionals and families in managing MPS patients

 

COURSE DESCRIPTION

Misdiagnosis of Mucopolysaccharidosis (MPS) results in late diagnosis and the late start of treatment, which has significant consequences on long-term outcomes. This gap usually results in confusing symptoms with other conditions, most notably trying to address symptoms directly and delaying actual diagnosis and treatment or referring the patient to the wrong pediatric specialties, causing further delays in the condition’s management chain.

The Spot the Early Signs program aims to fight under-diagnosed or late-diagnosed conditions for which treatments are available and where early detection and early treatment could make a significant difference in the condition's development, the quality of life and the survival of patients.


AUDIENCE

This educational activity is designed for an international audience of General Pediatricians, General Practitioners, Pediatric Endocrinologists, Pediatric Rheumatologists, and other physicians and healthcare professionals interested in Metabolic Diseases.

 


Watch the video!